| Emerging concepts and technologies in vaccine development M Brisse, SM Vrba, N Kirk, Y Liang, H Ly Frontiers in immunology 11, 583077, 2020 | 227 | 2020 |
| Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats SM Vrba, NM Kirk, ME Brisse, Y Liang, H Ly Vaccines 8 (4), 680, 2020 | 67 | 2020 |
| Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium JP Shannon, SM Vrba, GV Reynoso, E Wynne-Jones, O Kamenyeva, ... Immunity 54 (2), 276-290. e5, 2021 | 33 | 2021 |
| Zika virus spreads through infection of lymph node-resident macrophages GV Reynoso, DN Gordon, A Kalia, CC Aguilar, CS Malo, M Aleshnick, ... Cell reports 42 (2), 2023 | 15 | 2023 |
| Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines (Basel) 8: 680 SM Vrba, NM Kirk, ME Brisse, Y Liang, H Ly | 8 | 2020 |
| Antiviral activities of group I innate lymphoid cells RA Lujan, SM Vrba, HD Hickman Journal of molecular biology 434 (6), 167266, 2022 | 4 | 2022 |
| Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer–binding factor 1 SC Chan, SS Hajarnis, SM Vrba, V Patel, P Igarashi Journal of Biological Chemistry 295 (51), 17560-17572, 2020 | 4 | 2020 |
| Protocol for analyzing and visualizing antiviral immune responses after acute infection of the murine oral mucosa JP Shannon, CR Cherry, SM Vrba, HD Hickman STAR protocols 2 (4), 100790, 2021 | 3 | 2021 |
| Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice NM Kirk, Q Huang, S Vrba, M Rahman, AM Block, H Murphy, DW White, ... Frontiers in immunology 14, 1127515, 2023 | 2 | 2023 |
| Imaging viral infection in vivo to gain unique perspectives on cellular antiviral immunity SM Vrba, HD Hickman Immunological reviews 306 (1), 200-217, 2022 | | 2022 |
| SARS-CoV-2-INFECTED MACAQUES EXHIBIT MICROBIAL TRANSLOCATION ACROSS INTESTINAL MUCOSA K Brooks, C Nelson, C Aguilar, C Langner, S Vrba, A Ortiz, O Sortino, ... Topics in Antiviral Medicine, 74-75, 2022 | | 2022 |
| ILC1 and TRM occupy the same mucosal barrier niche and provide non-overlapping protection against infection S Vrba, E Wynne-Jones, G Reynoso, C Malo, J Shannon, H Hickman The Journal of Immunology 206 (1_Supplement), 103.35-103.35, 2021 | | 2021 |
| https://www. jbc. org/cgi/doi/10.1074/jbc. RA120. 015592 The latest version is at SC Chan, SS Hajarnis, SM Vrba, V Patel, P Igarashi | | |
